Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Oct;35(4):640-648.
doi: 10.1007/s12288-019-01123-8. Epub 2019 Apr 17.

Evaluation of Cytogenetic Abnormalities in Patients with Acute Lymphoblastic Leukemia

Pavan Reddy #  1 , Ramesh Shankar #  2 , Teena Koshy  3 , Venkatraman Radhakrishnan  1 , Prasanth Ganesan  1 , P K Jayachandran  1 , Manikandan Dhanushkodi  1 , Nikita Mehra  1 , S Krupashankar  1 , P Manasa  2 , R P Nagare  2 , R Swaminathan  4 , Krishnarathinam Kannan  1 , T G Sagar  1 , T S Ganesan  1
Affiliations

Evaluation of Cytogenetic Abnormalities in Patients with Acute Lymphoblastic Leukemia

Pavan Reddy et al. Indian J Hematol Blood Transfus. 2019 Oct.

Abstract

Acute lymphoblastic leukemia (ALL) accounts for 20% of all adult leukemias and is the most common leukemia during childhood (80%). We present data on cytogenetics of ALL from a tertiary centre in India correlating it with clinical factors. Karyotyping of bone marrow samples of 204 patients with newly diagnosed ALL was performed with standard G-banding technique. Clinical data of patients was obtained from case records. Survival was estimated using Kaplan-Meir curves and compared by the log-rank test. Univariate and multivariate analysis was done for survival with age, sex, immunophenotype, hyperleukocytosis, risk type, remission status and cytogenetics. The most common karyotypes observed were normal in 39.7% (N = 81), hyperdiploidy in 12.7% (N = 26), t(9;22) in 4.4% (N = 9), t(1;19) in 3.9% (N = 8). Adults with ALL had worse survival compared with pediatric patients (HR 3.62; 2.03-6.45 95% CI, p < 0.001). Patients not in morphologic remission after induction chemotherapy fared poorly (HR 4.86; 2.67-8.84 95% CI, p < 0.001). Patients with favourable cytogenetics had better overall survival (HR 0.36; 0.12-1.05 95% CI, p < 0.05). On multivariate analysis, achievement of morphologic remission emerged as single most significant predictor of survival (p < 0.001). MLL gene rearrangement and t(12;21) were seen less commonly as compared to Western data. However, incidence rates of various cytogenetic abnormalities were similar to that reported from other centres from India. Age, morphologic remission at end of induction chemotherapy and favourable cytogenetics correlated significantly with survival.

Keywords: Acute lymphoblastic leukemia; Cytogenetics; India; Karyotype; Overall survival.

PubMed Disclaimer

Conflict of interest statement

Conflict of interestThe authors declare that they have no conflict of interest.

Figures

Fig. 1
Fig. 1
Overall and relapse free survival curves. The left panel is overall survival and right is relapse free survival. The overall difference between children (solid line) and adults (dotted line) (a); the difference between those who achieved remission at end of 1 month (solid line) versus those who had residual disease (dotted line) (b); the difference in survival between patients who had favourable (solid line) versus normal cytogenetics (dotted line) (c)
Fig. 2
Fig. 2
Karyotype of patients with hyperdiploidy a hyperdiploidy; b t(1;19); c t(9;22); d t(12;21); e t(9;11;22)
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012. CA Cancer J Clin. 2012;62(1):10–29. doi: 10.3322/caac.20138. - DOI - PubMed
    1. Swaminathan R, Rama R, Shanta V. Childhood cancers in Chennai, India, 1990–2001: incidence and survival. Int J Cancer. 2008;122(11):2607–2611. doi: 10.1002/ijc.23428. - DOI - PubMed
    1. Terwilliger T, Abdul-Hay M. Acute lymphoblastic leukemia: a comprehensive review and 2017 update. Blood Cancer J. 2017;7(6):e577. doi: 10.1038/bcj.2017.53. - DOI - PMC - PubMed
    1. Mrózek K, Harper DP, Aplan PD. Cytogenetics and molecular genetics of acute lymphoblastic leukemia. Hematol Oncol Clin North Am. 2009;23(5):991–1010. doi: 10.1016/j.hoc.2009.07.001. - DOI - PMC - PubMed
    1. Inaba H, Greaves M, Mullighan CG. Acute lymphoblastic leukaemia. Lancet. 2013;381(9881):1943–1955. doi: 10.1016/S0140-6736(12)62187-4. - DOI - PMC - PubMed

LinkOut - more resources